Iowa Biotechnology Association (IowaBio)’s Post

New year, new opportunities for #agbioscience ✨ Where plants, animals and people collide, Indiana is positioned to shape the next chapter in agbioscience innovation. From the presence of life science leaders such as Eli Lilly and Company, Corteva Agriscience and Elanco to a thriving startup scene with emerging innovators such as BiomEdit, True Essence Foods and Liberation Labs, Indiana is in a unique position to seize the opportunity and continue to advance the #agbiosciences across the state, and beyond. Read the story from AFN: https://lnkd.in/gDQk3Jqp

We recommend/ "Bio-PAT Forum" online on 06. – 08. March 2024 (Free participation) 𝗨𝗻𝗹𝗼𝗰𝗸 𝘁𝗵𝗲 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 𝗼𝗳 𝗕𝗶𝗼𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗟𝗮𝘁𝗲𝘀𝘁 𝗶𝗻 𝗣𝗔𝗧 𝗮𝘁 𝘁𝗵𝗲 𝗕𝗶𝗼-𝗣𝗔𝗧 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟰 🚀   In an era where biotechnology is paving the way for groundbreaking advancements in healthcare, agriculture, and environmental sustainability, understanding and leveraging the power of #bioprocessing and Process Analytical Technology (#PAT) has never been more crucial. Join the 𝗕𝗶𝗼-𝗣𝗔𝗧 𝗙𝗼𝗿𝘂𝗺, an exclusive online event from March 6th to 8th, 2024, where innovation meets industry and academia.   𝗪𝗵𝘆 𝗮𝘁𝘁𝗲𝗻𝗱? 🌟 • 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗖𝘂𝘁𝘁𝗶𝗻𝗴-𝗘𝗱𝗴𝗲 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝗶𝗲𝘀: Learn about the latest innovations in bioprocessing and PAT from the leaders in the field. • 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝘄𝗶𝘁𝗵 𝗘𝘅𝗽𝗲𝗿𝘁𝘀: Connect with industry professionals, academic leaders, and potential partners to expand your professional network. • 𝗦𝗵𝗼𝘄𝗰𝗮𝘀𝗲 𝗬𝗼𝘂𝗿 𝗪𝗼𝗿𝗸: Seize the opportunity to present your company or institution in a 5-minute pitch. Simply email [email protected] with your presentation title to secure your spot.   𝗘𝘃𝗲𝗻𝘁 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: 🤝 • 𝗞𝗲𝘆𝗻𝗼𝘁𝗲 𝗦𝗽𝗲𝗲𝗰𝗵: Don't miss the keynote by Dr. M. Nicolas Cruz B., Head of the Future Bioprocessing Lab "KIWI-biolab", on "Integrating PAT in High Throughput Bioprocess Development". • 𝗜𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝗦𝗲𝘀𝘀𝗶𝗼𝗻𝘀: Engage in talks and short pitches by members of the Bio-PAT e.V. network, showcasing their competencies, products, and services, along with collaboration opportunities.   𝗝𝗼𝗶𝗻 𝗳𝗼𝗿 𝗙𝗿𝗲𝗲: Participation is complimentary – secure your place now by signing up at https://lnkd.in/esbMgZR5. For a detailed agenda, please visit https://lnkd.in/eN3aMb4S.   𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀? For further inquiries, feel free to contact Anika B. at [email protected]. #processanalytics #processanalysis #biotechnology

Just like that, #bioeurope2023 is wrapping up. This experience has been truly exhilarating and has shown clear evidence that the industry in boucing back after a period of uncertainty due to the pandemic. We’ll still be around the Bayern booth for the closing hours if you’re interested in learning more about LSR before we say goodbye. #bioeurope, #lifesciences

In this conversation, Enric Queralt Creus, CEO of Bluephage, celebrates the company's 7-year history and discusses how the Enumera Rapid Quantitative Kit will impact the safety of water sources around the world. Queralt anticipates the market's response to the new test kit and shares insights into the strategies implemented to ensure its wide adoption, emphasizing the importance of effective marketing and navigating the complexities of global approvals. The interview also explores Bluephage's commitment to partnership-building in the biotech industry, clarifying collaborations aimed at enhancing the accessibility of the coliphage Rapid Quantitative Enumerative Kit and contributing to #WaterQuality management initiatives on a larger scale. Looking ahead, the article reveals Bluephage's strategic vision for continued innovation in the water quality testing sector. Queralt discusses ongoing collaborations with the Universitat de Barcelona, upcoming product launches, and the company's commitment to expanding its portfolio to address evolving challenges in water management worldwide. https://lnkd.in/du278YJb

🎉 Next Milestone Unveiled: Successful Bioprocess Scale Up Achieved! 🌱🏭 Thrilled to announce a groundbreaking accomplishment in our collaboration with our partners Universitat Autònoma de Barcelona and Bisy! 🤝 Our joint efforts at the Bio Base Europe Pilot Plant have led to the successful scale-up of a cutting-edge bioprocess. 🚀 📊 Scaling New Heights: Witnessing the transition from laboratory innovation to large-scale production is a testament to the prowess of industrial biotechnology. The project about engineering oxygenases for integrated bioprocesses, meticulously developed and optimized, is now ready to make a real impact on a grand scale. 🤖 Seamless Integration: Special thanks to the innovative minds at Bisy such as Anton (Toni) Glieder for their unwavering dedication and seamless collaboration. Together, we've navigated challenges, harnessed technology, and triumphed over complexities to bring this vision to life. 🔬 Pioneering Biotechnology: This achievement not only marks a significant step forward in our journey but also highlights the transformative potential of biotechnology in shaping a sustainable future. 🌍 📸 A snapshot capturing the essence of our collaboration and the momentous scale-up achievement at Bio Base Europe Pilot Plant. Kudos to the entire team involved for turning vision into reality! 👏 Let's continue pushing the boundaries of innovation and forging the path to a more sustainable and bio-based future. #BioprocessScaleUp #IndustrialBiotechnology #InnovationMilestone #CollaborationSuccess #SustainableFuture #BiotechnologyAdvancements #acib #bisy #BioBaseEuropePilotPlant #BioTechInnovation 🌿🔬

🔬🌍 Join the Biolamer Project Initiative: Your Expertise is Needed! We are excited to share a new initiative of the European-funded project BioLaMer. This groundbreaking action aims to tackle key challenges in the production and commercialization of bioplastics through evidence-based recommendations.   📢 Calling All Bioplastic Industry Stakeholders! BioLaMer is now conducting interviews across Europe and we need your valuable input. If you are involved in the bioplastic industry, we invite you to participate in our study. Your insights and experiences are crucial to advancing the field and establishing best practices. 🔒 Your Privacy Matters - All data will be anonymized and analyzed collectively. - By participating, you will receive the global results directly from our research team.- You'll be invited to future events such as workshops and networking encounters. 📩 If you're interested in participating or would like more information about this project, please don't hesitate to reach out. For more information please head to the website: https://biolamer.eu/ Let's work together to shape the future of bioplastics! 🌱✨   #BioLaMer #Bioplastics #Sustainability #Innovation #Research #EuropeanProject #IndustryCollaboration #Networking #EcoFriendly

Advances in pharma and biotech are critical for the progression of modern medicine, but at what cost to the environment? In this exclusive video interview with Technology Networks, My Green Lab’s CEO James Connelly discussed why our recently released 2023 Carbon Impact of Biotech and Pharma report is so important, its key findings, and steps that laboratories can take to reduce their carbon emissions. Watch the video here: https://lnkd.in/g7m-UG-A Download the 2023 report here: https://lnkd.in/eC5cUkun

📅➡️ Have you been keeping up with the latest discoveries? We've already had a fantastic year connecting with industry leaders and sharing our insights at some of the most prestigious events in the life science and healthcare sector. 🧬But there is more to come! Continue this journey with us as we head to more key events, ready to unveil our latest research and innovative approaches. 𝗦𝘄𝗶𝗽𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝘁𝗼 𝘀𝗲𝗲 𝘄𝗵𝗲𝗿𝗲 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝘂𝘀 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝘄𝗲'𝗹𝗹 𝗯𝗲 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝗻𝗲𝘅𝘁. #ESMO #BioTechX #BioEurope

Synbiobeta last week was awesome! Maybe one of the best conferences I have attended. Not only were there talks by great scientists like Paul Stamets 🍄 and Craig Venter (picture below), but I reconnected with fermentation people at Genencor/DuPont/IFF, and BASF. Furthermore, I was able to meet many other innovators/service providers/investors during the conference. I feel very blessed to have spent two decades in this field. Although summarizing what I saw in bullet points is difficult, here it goes: • The conference felt very commercial in comparison to when it started, and not in a bad way. This is an indication that biotech has evolved over the past decade from the abstract or medical to the very practical. • The ecosystem is vibrant. There are many start-ups, service providers, innovators and investors from different countries all under one roof. To be candid, I was gladly surprised to see a couple of the Fortune 500 companies I worked for in the conference. • AI 🧠 is impacting everything including biotech. Although there are a lot of initiatives only time will tell which ones are the ones that will pan out commercially. Huge shout-out to Ginkgo Bioworks, Inc. and SynBioBeta for providing our start-up with a grant so that we could attend. I won't tag names, but building a start-up, just like raising a child 👶, takes a village. #synbio #synbiobeta #biotech #fermentation

Syensqo is committed to exploring the future of science. You only have to look at the pioneering work of the brilliant scientists who attended the Solvay conference of 1911. Their forward-thinking mindset, changed the world as we know it and laid the foundations for the work we do at Syensqo! Martin Hans Christian Knudsen was one of the 24 brightest stars at the conference. His equation and work help explain the kinetic theory of gas and are still used in industrial applications today. Grow your career with us, and your innovative work could affect processes in the decades to come: https://bit.ly/3U1of1P #AdvancingHumanity